cidofovir anhydrous has been researched along with Cancer of Head in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeitels, SM | 1 |
| Andrei, G; Mertens, B; Naesens, L; Nogueira, T; Snoeck, R; Stranska, R | 1 |
| Aaltonen, LM; Andersen, J; Brunings, JW; Chirila, M; de Gier, HH; Dietz, A; Dikkers, FG; Ferran Vilà, F; Friedrich, G; Golusinski, W; Graupp, M; Hantzakos, A; Horcasitas, R; Ilmarinen, T; Jackowska, J; Koelmel, JC; Lawson, G; Lindner, F; Remacle, M; Sittel, C; Tjon Pian Gi, RE; van den Heuvel, ER; Weichbold, V; Wierzbicka, M | 1 |
| Ferris, RL; Sirianni, N; Wang, J | 1 |
| Abdulkarim, B; Bourhis, J; Chagraoui, H; Chouaïb, S; Deutsch, E; Eschwege, F; Maggiorella, L; Sabri, S; Thierry, J; Vainchenker, W | 1 |
5 other study(ies) available for cidofovir anhydrous and Cancer of Head
| Article | Year |
|---|---|
Glottic Cancer: A Metamorphosing Disease.
Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Cytosine; Diagnostic Errors; Female; Glottis; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Laryngoscopy; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Retrospective Studies; Smoking; Squamous Cell Carcinoma of Head and Neck | 2016 |
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
Topics: Antiviral Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cidofovir; Cytosine; DNA Damage; Female; Head and Neck Neoplasms; HeLa Cells; Humans; Male; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms | 2016 |
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Cytosine; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Male; Neutropenia; Off-Label Use; Organophosphonates; Papillomavirus Infections; Renal Insufficiency; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2013 |
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
Topics: Adult; Antiviral Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Survival; Cidofovir; Cytosine; Head and Neck Neoplasms; Humans; Male; Neoplasm Proteins; Oncogene Proteins, Viral; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Radiation Tolerance; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2005 |
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Radiation-Sensitizing Agents; Radiation, Ionizing; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2002 |